Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 10, 2025

BUY
$69.3 - $90.95 $17,255 - $22,646
249 Added 1.57%
16,123 $1.12 Billion
Q4 2024

Jan 13, 2025

BUY
$85.0 - $120.04 $379,440 - $535,858
4,464 Added 39.12%
15,874 $1.37 Billion
Q3 2024

Oct 15, 2024

BUY
$119.07 - $145.42 $1.36 Million - $1.66 Million
11,410 New
11,410 $1.36 Billion

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $109B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Signal Advisors Wealth, LLC Portfolio

Follow Signal Advisors Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signal Advisors Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signal Advisors Wealth, LLC with notifications on news.